iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Holders of 5% or more of ITOS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of iTeos Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Tang Capital Management LLC | 13D/A | 100.00%10.0K shares | +90.01 ppfrom 9.99% | Sep 30, 20246 filings | Sep 3, 2025 | SEC |
| EcoR1 Capital, LLC | 13D | 27.90%10.7M shares | +13.00 ppfrom 14.90% | Feb 16, 20245 filings | May 16, 2025 | SEC |
| BlackRock Portfolio Management LLC | 13G | 6.10%2.33M shares | New | Apr 15, 20251 filing | Apr 15, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 5.70%2.18M shares | – | Oct 21, 20243 filings | Apr 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
52 Schedule 13D and 13G filings on iTeos Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:03 PM ET | Ridgeback Capital Investments L.P.and 2 others | 13G/A | 0.00%0 shares | −5.10 ppfrom 5.10%Below 5% | Sep 30, 2025 | SEC |
| Sep 3, 20254:15 PM ET | Tang Capital Management LLCand 7 others | 13D/A | 100.00%10.0K shares | +90.01 ppfrom 9.99% | Aug 29, 2025 | SEC |
| Aug 14, 20254:03 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 0.00%0 shares | −8.10 ppfrom 8.10%Below 5% | Jun 30, 2025 | SEC |
| Jul 25, 20254:03 PM ET | Ridgeback Capital Investments L.P.and 2 others | 13G | 5.10%1.94M shares | +1.30 ppfrom 3.80% | Jul 21, 2025 | SEC |
| Jul 22, 20254:31 PM ET | Tang Capital Management LLCand 6 others | 13D/A | 9.99%3.83M shares | 0.00 ppfrom 9.99% | Jul 18, 2025 | SEC |
| Jun 12, 20254:27 PM ET | Tang Capital Management LLCand 6 others | 13D | 9.99%3.83M shares | 0.00 ppfrom 9.99% | Jun 11, 2025 | SEC |
| Jun 4, 20254:00 PM ET | Ridgeback Capital Investments L.P.and 2 others | 13G | 3.80%1.44M shares | NewBelow 5% | May 28, 2025 | SEC |
| May 19, 20255:46 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 4.90%2.13M shares | −5.00 ppfrom 9.90%Below 5% | May 15, 2025 | SEC |
| May 16, 20257:22 PM ET | EcoR1 Capital, LLCand 2 others | 13D | 27.90%10.7M shares | +13.00 ppfrom 14.90% | May 15, 2025 | SEC |
| May 15, 20255:30 PM ET | MPM BioVentures 2014, L.P.and 15 others | 13D/A | 4.70%1.80M shares | –Below 5% | May 13, 2025 | SEC |
| May 15, 20254:35 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 8.10%3.08M shares | – | Mar 31, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G | 9.99%3.83M shares | +9.39 ppfrom 0.60% | May 13, 2025 | SEC |
| May 14, 20256:34 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 9.90%4.16M shares | – | May 12, 2025 | SEC |
| May 13, 20257:10 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 14.90%5.73M shares | +8.00 ppfrom 6.90% | May 13, 2025 | SEC |
| May 8, 20257:43 PM ET | EcoR1 Capital, LLCand 2 others | 13G | 6.90%2.66M shares | – | May 1, 2025 | SEC |
| Apr 23, 20258:57 PM ET | BlackRock, Inc. | 13G/A | 5.70%2.18M shares | – | Mar 31, 2025 | SEC |
| Apr 15, 20255:04 PM ET | BlackRock Portfolio Management LLC | 13G | 6.10%2.33M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20254:00 PM ET | Tang Capital Management LLCand 4 others | 13G/A | 0.60%221.7K shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 21, 2024 | Biotechnology Value Fund L P | 13GOld format | – | – | – | SEC |
| Nov 18, 2024 | Boxer Capital Management, LLC | 13D/AOld format | – | – | – | SEC |
| Nov 18, 2024 | Boxer Capital Management, LLC | 13D/AOld format | – | – | – | SEC |
| Nov 14, 2024 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 21, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 15, 2024 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Oct 15, 2024 | Boxer Asset Management Inc. | 13D/AOld format | – | – | – | SEC |
| Sep 30, 2024 | Tang Capital Management LLC | 13GOld format | – | New | – | SEC |
| May 14, 2024 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| May 14, 2024 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2024 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 23, 20244:13 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 9, 2024 | Millennium Management LLC | 13G/AOld format | – | – | – | SEC |
| Oct 24, 2023 | Millennium Management LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Jan 26, 20238:52 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 20, 20235:17 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jul 8, 20224:56 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| May 11, 2022 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| May 2, 2022 | Biotechnology Value Fund L P | 13GOld format | – | New | – | SEC |
| Mar 21, 2022 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Jan 6, 2022 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Dec 10, 2021 | MPM BioVentures 2014, L.P. | 13D/AOld format | – | – | – | SEC |
| Oct 19, 2021 | MPM BioVentures 2014, L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 21, 2021 | MPM BioVentures 2014, L.P. | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
9 notices from officers, directors and other affiliates planning to sell iTeos Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 20254:19 PM ET | Detheux MichelOfficer | 52.3K | $523.9K | Jun 10, 202510b5-1 | UBS Financial Services Inc | SEC |
| Jun 9, 20254:12 PM ET | Detheux MichelOfficer | 52.3K | $531.7K | Jun 9, 202510b5-1 | UBS Financial Services Inc | SEC |
| Jun 6, 20254:11 PM ET | Detheux MichelOfficer | 52.3K | $532.8K | Jun 6, 202510b5-1 | UBS Financial Services Inc | SEC |
| Jun 6, 20254:09 PM ET | David L HallalDirector | 38.2K | $391.5K | Jun 6, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 5, 20254:27 PM ET | David L HallalDirector | 38.2K | $388.1K | Jun 5, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 5, 20254:10 PM ET | Detheux MichelOfficer | 52.3K | $534.3K | Jun 5, 202510b5-1 | UBS Financial Services Inc | SEC |
| Jun 4, 20254:03 PM ET | Detheux MichelOfficer · President and CEO | 52.3K | $526.0K | Jun 4, 202510b5-1 | UBS Financial Services Inc | SEC |
| Jun 4, 20254:03 PM ET | David L HallalDirector | 38.2K | $384.8K | Jun 4, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 23, 20239:35 PM ET | Boxer Capital, LLCSeller's CEO is Director of Issuer | 350.0K | $4.11M | Aug 23, 2023 | Bank of America, N.A. | SEC |